gnrh-a ( buserelin ) was infused continuously through the subcutaneous route at rates of 200 micrograms ( group i ; n = 5 ) , 100 micrograms ( group ii , n = 4 ) and 10 micrograms ( group iii ; n = 4 ) per day for 24 weeks .
C0023610
gnrh
C0006456
buserelin